Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial

Rainer Fietkau; Michael B. Ghadimi; Robert Grützmann; Uwe A. Wittel; Lutz Jacobasch; Waldemar H. Uhl; Roland S. Croner; Wolf O. Bechstein; Ulf Peter Neumann; Dirk Waldschmidt; Stefan Hubert Boeck; Nicolas Moosmann; Anke Reinacher‐Schick; Henriette Golcher; Werner Adler; Sabine Semrau; Dorota Łubgan; Annett Kallies; Markus Hecht; Iris Tischoff; Andrea Tannapfel; Benjamin Frey; Helmut Oettle; on behalf of the CONKO Study Group

doi:10.1200/jco-25-03004

Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial

Journal of Clinical Oncology 2026 Open access

Read full text

Authors: Rainer Fietkau, Michael B. Ghadimi, Robert Grützmann, Uwe A. Wittel, Lutz Jacobasch, Waldemar H. Uhl, Roland S. Croner, Wolf O. Bechstein, Ulf Peter Neumann, Dirk Waldschmidt, Stefan Hubert Boeck, Nicolas Moosmann

+12 more

Anke Reinacher‐Schick, Henriette Golcher, Werner Adler, Sabine Semrau, Dorota Łubgan, Annett Kallies, Markus Hecht, Iris Tischoff, Andrea Tannapfel, Benjamin Frey, Helmut Oettle, on behalf of the CONKO Study Group

DOI: 10.1200/jco-25-03004

Cited by: 0

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies Pancreatitis Pathology and Treatment

Publication details

Journal / source: Journal of Clinical Oncology
Volume: 44
Issue: 5
Pages: 430–430
Publication date: 8 January 2026
Language: EN